Advancing of cellular signaling pathways in respiratory diseases using nanocarrier based drug delivery systems

M Mehta, DS Dhanjal, S Satija… - Current …, 2020 - ingentaconnect.com
Cell Signaling pathways form an integral part of our existence that allows the cells to
comprehend a stimulus and respond back. Such reactions to external cues from the …

Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis

LÁ Ibarra-Sánchez, A Gámez-Méndez… - Journal of Drug Delivery …, 2022 - Elsevier
Respiratory diseases are leading causes of death and disability in developing and
developed countries. The burden of acute and chronic respiratory diseases has been rising …

Nanocarriers for respiratory diseases treatment: recent advances and current challenges

A Trapani, S Di Gioia, S Castellani… - Current Topics in …, 2014 - ingentaconnect.com
Pulmonary delivery of locally-acting drugs encapsulated in nanocarriers provides several
advantages for the treatment of respiratory diseases such as asthma, chronic obstructive …

Application of nanotechnology in drug delivery systems for respiratory diseases

MX Luo, S Hua, QY Shang - Molecular Medicine …, 2021 - spandidos-publications.com
Respiratory disease is a common disease with a high incidence worldwide, which is a
serious threat to human health, and is considered a societal and economic burden. The …

[HTML][HTML] Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations–A review

M Kumar, AR Hilles, SHA Almurisi, A Bhatia… - JCIS Open, 2023 - Elsevier
The lung is an attractive target for drug delivery because of the ease of non-invasive
administration via inhalation, bypassing metabolism in the liver, direct delivery to the …

Nanotechnology: Advancing the translational respiratory research

K Dua, SD Shukla… - … Medicine and Applied …, 2017 - akjournals.com
Considering the various limitations associated with the conventional dosage forms,
nanotechnology is gaining increased attention in drug delivery particularly in respiratory …

A comprehensive review of current perspectives on novel drug Delivery systems and approaches for lung cancer management

U Hani, S Wahab, A Siddiqua, RAM Osmani… - Journal of …, 2021 - Springer
Cancer is one of the fatal diseases that cause many deaths around the world. Lung cancer
has the highest incidence and mortality rates among cancer-related death worldwide. Lung …

Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases

S Pramanik, S Mohanto, R Manne… - Molecular …, 2021 - ACS Publications
Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …

Special focus issue on targeted drug delivery for inflammatory lung diseases

K Dua, R Lobenberg, DK Chellappan - Nanomedicine, 2022 - Taylor & Francis
There are reportedly over five million annual deaths worldwide due to lung-related diseases.
A majority of these subjects suffer from asthma and chronic obstructive pulmonary diseases …

Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy

Z Jin, Q Gao, K Wu, J Ouyang, W Guo… - Advanced Drug Delivery …, 2023 - Elsevier
The lack of effective treatments for pulmonary diseases presents a significant global health
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …